Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.15
-0.16 (-2.46%)
May 13, 2025, 4:00 PM - Market closed
Inogen Market Cap
Inogen has a market cap or net worth of $165.22 million as of May 14, 2025. Its market cap has increased by 9.27% in one year.
Market Cap
165.22M
Enterprise Value
65.41M
1-Year Change
9.27%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since February 14, 2014, Inogen's market cap has decreased from $274.90M to $165.22M, a decrease of -39.90%. That is a compound annual growth rate of -4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 169.40M | -22.44% |
| Dec 31, 2024 | 218.40M | 70.63% |
| Dec 29, 2023 | 128.00M | -71.67% |
| Dec 30, 2022 | 451.80M | -41.52% |
| Dec 31, 2021 | 772.60M | -21.82% |
| Dec 31, 2020 | 988.20M | -34.26% |
| Dec 31, 2019 | 1.50B | -43.75% |
| Dec 31, 2018 | 2.67B | 7.54% |
| Dec 29, 2017 | 2.49B | 82.61% |
| Dec 30, 2016 | 1.36B | 72.72% |
| Dec 31, 2015 | 787.90M | 34.82% |
| Dec 31, 2014 | 584.40M | 112.59% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |